Le sintilimab (anti-PD1) et chimiothérapie dans la prise en charge du CBNPC épidermoïde
Sintilimab plus platinum and gemcitabine as first-line treatment for advanced or metastatic squamous non-small-cell lung cancer: results from a randomized, double-blind, phase 3 trial (ORIENT-12). Zhou et al. J Thorac Oncol. 2021 [...]